Evidence map›Paper›PMID 40508517›Full record

ArticleMaterials (Basel, Switzerland)2025

Synthesis and Photochromic Properties of Diarylethene Derivatives with Aggregation-Induced Emission (AIE) Behavior.

Jiaxin Guo, Haoyuan Yu, Yuhua Jin

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiaxin GuoSchool of Chemical Engineering, East China University of Science and Technology, Shanghai 200237, China.
Haoyuan YuShanghai StarryInk Biotechnology Co., Ltd., Shanghai 200080, China.
Yuhua JinSchool of Science and Engineering, The Chinese University of Hong Kong, Shenzhen 518172, China.ORCID 0009-0009-3353-3712

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photochromic materials have attracted widespread attention due to their potential applications in optical information storage, optoelectronic devices, and fluorescence probes. As a typical photochromic system, diarylethene derivatives are considered one of the most promising photochromic materials due to their outstanding photostability and significant bistable properties. Based on an aggregation-induced emission (AIE) mechanism, this study employed a molecular structural engineering strategy to design and synthesize a series of diarylethene derivatives containing ethyl benzoate substituents. A systematic investigation of the structure-activity relationship between their photochromic behavior and AIE characteristics revealed a dual-state light response mechanism in the solid and solution states. This study demonstrates that the target compounds exhibited significant photochromic responses under UV-visible light irradiation, with enhanced emission in the solid state compared to the solution state, confirming the remarkable enhancement effect of AIE on aggregation. Structural characterization techniques such as nuclear magnetic resonance spectroscopy (NMR) and high-resolution mass spectrometry (H RMS) were employed to elucidate the correlation between molecular conformation and photophysical properties. Furthermore, these materials demonstrated potential for multi-level anti-counterfeiting, high-density optical storage, and bioimaging applications, providing experimental foundations for the development of novel multifunctional photochromic materials.

Indexed as

aggregation-induced emission effectdiarylethene derivativesphotophysical propertiesphotoresponsivity properties

Identifiers

PMID40508517
PMCPMC12156935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.